Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial

Vilmarie Rodriguez, Sarah O'Brien, Glen Lew, Etan Orgel, Kimberly Derr, Mark A. Ranalli, Corinna L. Schultz, Adam J. Esbenshade, Arteid Memaj, Joshua Dyme, Nicholas Favatella, Lesley Mitchell

Blood (2023) 142 (Supplement 1): 810.

https://doi.org/10.1182/blood-2023-180037

Published: 2023

Journal Articles

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Jacqueline Halton, MD, Leonardo R. Brandao, MD, Matteo Luciani, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Ildar Nurmeev, MD, Anjali Sharathkumar, MD, Pavel Svirin, MD, Kirill Gorbatikov, MD, Igor Tartakovsky, MD, Monika Simetzberger, DI, Fenglei Huang, PhD, Zhichao Sun, PhD, Jörg Kreuzer, MD, Savion Gropper, MD, Martina Brueckmann, MD, Manuela Albisetti, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136682

Published: 2020

Journal Articles

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Leonardo R. Brandao, MD, Igor Tartakovsky, MD, Manuela Albisetti, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Matteo Luciani, MD, Paola Saracco, MD, Judy Felgenhauer, MD, Olga Lvova, MD, Monika Simetzberger, DI, Zhichao Sun, PhD, Ingrid Gergei, MD, Martina Brueckmann, MD, Jacqueline Halton, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136695

Published: 2020

Journal Articles

Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study

Lesley Mitchell, Moritz Lambers, Silke Flege, Gili Kenet, Valerie Li-Thiao-Te, Susanne Holzhauer, Christoph Bidlingmaier, Michael C. Frühwald, Christine Heller, Wolfgang Schmidt, Brigitte Pautard, Ulrike Nowak-Göttl

Blood (2010) 115 (24): 4999–5004.

https://doi.org/10.1182/blood-2010-01-263012

Published: 2010

Journal Articles

Population Pharmacokinetics of Enoxaparin in Children at Risk for Symptomatic Thromboembolism.

Mirjam Nadine Trame, Lesley Mitchell, MSc, Christoph Male, MD, MSC, Jeffrey S. Barrett, PhD, Georg Hempel, Ulrike Nowak-Gottl, MD

Blood (2009) 114 (22): 1071.

https://doi.org/10.1182/blood.V114.22.1071.1071

Published: 2009

Journal Articles

Validation of a Predictive Model for Indentifying An Increased Risk for Thromboembolism in Children with Acute Lymphoblastic Leukemia: Results of a Multicenter Cohort Study

Silke Flege, Lesley Mitchell, MSc, Gili Kenet, Christine Heller, Michael Fruhwald, Ulrike Nowak-Gottl, MD

Blood (2008) 112 (11): 524.

https://doi.org/10.1182/blood.V112.11.524.524

Published: 2008

Journal Articles

Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus

Christoph Male, Denise Foulon, Hugh Hoogendoorn, Patricia Vegh, Earl Silverman, Michèle David, Lesley Mitchell

Blood (2005) 106 (13): 4152–4158.

https://doi.org/10.1182/blood-2005-05-2048

Published: 2005

Journal Articles

Central venous line–related thrombosis in children: association with central venous line location and insertion technique

Christoph Male, Peter Chait, Maureen Andrew, Kim Hanna, Jim Julian, Lesley Mitchell, the PARKAA Investigators

Blood (2003) 101 (11): 4273–4278.

https://doi.org/10.1182/blood-2002-09-2731

Published: 2003

Journal Articles

Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus

Christoph Male, Lesley Mitchell, James Julian, Patricia Vegh, Penny Joshua, Margaret Adams, Michelle David, Maureen E. Andrew

Blood (2001) 97 (4): 844–849.

https://doi.org/10.1182/blood.V97.4.844

Published: 2001

NARROW

Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study

Population Pharmacokinetics of Enoxaparin in Children at Risk for Symptomatic Thromboembolism.

Validation of a Predictive Model for Indentifying An Increased Risk for Thromboembolism in Children with Acute Lymphoblastic Leukemia: Results of a Multicenter Cohort Study

Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus

Central venous line–related thrombosis in children: association with central venous line location and insertion technique

Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only